IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,400 | +10.6% | 2,500 | 0.0% | 0.00% | – |
| Q2 2023 | $102,575 | -4.3% | 2,500 | -16.7% | 0.00% | – |
| Q1 2023 | $107,220 | +13.6% | 3,000 | +20.0% | 0.00% | – |
| Q4 2022 | $94,425 | -14.9% | 2,500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $111,000 | +19.4% | 2,500 | 0.0% | 0.00% | – |
| Q2 2022 | $93,000 | -7.9% | 2,500 | -7.9% | 0.00% | – |
| Q1 2022 | $101,000 | +26.2% | 2,714 | +3.4% | 0.00% | – |
| Q4 2021 | $80,000 | -9.1% | 2,626 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -13.7% | 2,626 | +2.8% | 0.00% | – |
| Q2 2021 | $102,000 | -76.3% | 2,554 | -73.3% | 0.00% | -100.0% |
| Q1 2021 | $430,000 | -21.2% | 9,558 | -1.0% | 0.00% | -33.3% |
| Q4 2020 | $546,000 | +4.0% | 9,658 | -12.7% | 0.00% | 0.0% |
| Q3 2020 | $525,000 | -20.5% | 11,062 | -1.1% | 0.00% | -25.0% |
| Q2 2020 | $660,000 | +24.8% | 11,188 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $529,000 | -15.6% | 11,188 | +7.8% | 0.00% | +33.3% |
| Q4 2019 | $627,000 | +43.8% | 10,382 | +42.6% | 0.00% | 0.0% |
| Q3 2019 | $436,000 | -8.8% | 7,282 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $478,000 | -15.8% | 7,434 | +6.3% | 0.00% | -25.0% |
| Q1 2019 | $568,000 | +48.7% | 6,994 | -1.1% | 0.00% | +33.3% |
| Q4 2018 | $382,000 | +4.1% | 7,071 | -0.7% | 0.00% | +50.0% |
| Q3 2018 | $367,000 | +15.4% | 7,118 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | +1.9% | 7,642 | +8.1% | 0.00% | 0.0% |
| Q1 2018 | $312,000 | +3020.0% | 7,071 | +3641.3% | 0.00% | – |
| Q4 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | +25.0% | 189 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | -11.1% | 189 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | +28.6% | 189 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +133.3% | 189 | +40.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 135 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -58.3% | 135 | -30.8% | 0.00% | – |
| Q4 2015 | $12,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |